Categories
All
Biotech
Clinical Trials
Health Tech
News
Pharma
Regulatory
A ‘Bariatric-Level’ Obesity Drug Is Coming: Retatrutide and the UK Reality
Trump FDA Drug Approvals: Global Impact
Most Supplement Companies Skip the RCT
Doctor, Patient, Agent: A New Clinical Triad for Medicine
Physiology: The Missing Layer in Precision Medicine
Weekly News Roundup | 27 April 2026
Life Science Daily News: Join the Community
Clinical Trials Roundup | 24 April 2026
AstraZeneca’s $18.5 Billion China Obesity Drug Deal Explained
Beyond Words: AI, Human-Centered Design, and the Future of Health Literacy
The iPS Era is Arriving – Now the Field Must Prove it Can Scale
Boehringer Ingelheim Opens AI Centre in London’s Knowledge Quarter
Natural Product Drug Discovery Returns With New Anti Cancer Insights
Biotech’s Funding Winter is Over, but M&A Will Remain Selective
A Career in Life Sciences: Pathways, Possibilities and Support
Obesity Redefinition Studies Challenge Longstanding Clinical Standards
Japan’s iPSC Breakthrough: A New Hope for Spinal Cord Injury Repair
Basecamp Research Debuts World’s First AI for Programmable Gene Insertion
Peptide and Biomolecule Research Bridges Consumer and Clinical Innovation
Lego for Biotech Labs
The Boom in Life Sciences in India
Windward Bio Strikes $700M Licensing Deal for Qyuns Immunology Bispecific
AI Drug Discovery Moves from Hype to Measurable Output
Top 5 Global Diseases and Future Outlook for Life Science Innovation
Experimental Alzheimer’s Pill Boosts the Brain’s Cleanup System
From Kennels to Clinics: Translating Veterinary Research to Human Trials
MRI Study Links Inflammation in Brain Reward Centre to Depression Severity
Functional Gut Clinic Launches GI Clinical Trials Division
Pharvaris Announces Positive Phase 3 Results for Deucrictibant
Otsuka Wins Approval for Novel Rare Kidney Drug
New Hope for Patients with Hereditary Hemorrhagic Telangiectasia
ALS- Clinical Signals of a “Synaptic Regenerative” Approach!
Ground-Breaking Gene Therapy for Hunter Syndrome
The Future of Clinical Trials: Virtual, Decentralised, and Patient-Led
US Scientists Create Human Embryos from Skin Cells
Stem Cell Breakthrough: Woman Reverses Type 1 Diabetes Using Her Own Cells
A Decentralized Advantage: Outpatient Theranostics is the Clinical Standard
The Convergence Era: How Data and AI are Reshaping Life Sciences
Pregnancy, the Brain, and the Nervous System
Australian Healthcare Reviews Mean Nothing Without the Right Governance
GMCA: Why Unlocking Longevity Research Will Drive Innovation
NIH Scientists Pioneer “Digital Twin” of Eye Cells
Doctors Warn AI Diet Advice Should Not Replace Medical Care
Fertility Decisions and AI: Clarity Without False Certainty
AI-Enabled Pathology: De-risking Oncology Drug Development
Why Sugar May Matter More Than We Thought
Cera and Promptly Health Partner to Bridge the ‘Evidence Gap’
RCM Efficiency: Solving Insurance Denials & Margin Pressure
Microplastics From Food Packaging Linked to Liver Damage, New Study Finds
Weekly News Roundup | 16 March 2026
Imperial, Oxford & GSK launch £11M Digital Twin Organ Centre
Redefining Fertility & Modern Motherhood with Dr. Roohi Jeelani and Hayley
Teaching Children Conscious Self-Regulation for Life Outcomes
Thermo Fisher Scientific Opens New Distribution Center in Ireland
From Living Room to Lab: New Dementia Study to Close Participation Gap
MSD Reorganises to Shield Growth from Impending “Keytruda Cliff”
PICTURE: Democratising Clinical Intelligence from the Frontline
Professor Chris Van Tulleken to Headline Smart Ageing Summit in May
UK Expertise: Faster Cancer Diagnosis and Cleaner Energy
Prices for GLP-1 Drugs Are Falling Fast and Forcing Companies to Adapt
J&J Axes Eczema Drug From $1.25B Acquisition
How the UK May Be Undervaluing Life Sciences Manufacturing Investments
Part II – Trade, Capital and the UK Life Sciences Strategy
Manufacturing and Supply Chain Resilience for Advanced Therapies
Part I – Platforms, Pipelines and Incentives in Global Biopharma
Are Mega-Deals Back for Real?
Pharma 5.0: The Future of Human-Centric, Intelligent, Sustainable Medicine
Autolus CAR-T Offers Hope to Adults with Aggressive Blood Cancer
Decision Frameworks in Pharma
Follow the Science? It Would Rather Follow a Leader… (2025 Update)
Durvalumab approved in the US
Novartis to Acquire Avidity in $12B RNA Therapy Deal
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.